Loading organizations...
Key people at Rimonci Capital.
Rimonci Capital was founded in 2016 by Eddie Wang (COO and Co-Founder) and Richel Liu (Founder and CEO).
Rimonci Capital is a venture capital firm investing within defined vertical sectors. Its strategy employs a concentrated approach, notably with the Rimonci Global Vision Science Fund, emphasizing technological and scientific innovation. The firm identifies and supports companies in specialized industries, applying targeted expertise to accelerate development and market presence.
The firm was founded in 2016 by CEO Ms. Richel Yuxiao Liu and Co-Founder Mr. Eddie Wang. Ms. Liu contributes prior executive experience. Their insight focused on the necessity for a specialized venture capital model within distinct industry verticals, enabling precise, impactful investments over generalized funding.
Rimonci Capital supports emerging companies seeking strategic funding and guidance across its vertical markets, including Israeli investments. The firm’s vision is to refine its specialized focus for a highly effective venture capital model. This strategy drives innovation and facilitates scalable expansion for promising enterprises, positioning Rimonci as a key strategic partner.
Rimonci Capital was founded in 2016 by Eddie Wang (COO and Co-Founder) and Richel Liu (Founder and CEO).
Key people at Rimonci Capital.
Rimonci Capital has 5 tracked investments across 4 companies. The latest tracked deal is $25.0M Series C in EyeYon in March 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 15, 2021 | EyeYon | $25.0M Series C | CR CP Life Science Fund | Brighton Park Capital, Diamond BioFund, Global Health Sciences Fund, Pontifax, Triventures |
| Aug 1, 2020 | EyeControl | $8.0M Series A | Connecticut Innovations | Itsik Danziger, AVI Kornreich, Benny Levin, JIM Elkind, Benslie International Fund, Impact First, Menomadin Foundation, Zora Ventures |
| Jul 22, 2020 | BELKIN Vision | $12.3M Series B | Rimonci Capital, Santen Ventures | BioLight Life Sciences, C MER EYE Care Holdings, CR CP Life Science Fund |
| Jul 13, 2020 | NovaSight | $8.0M Series A | Rimonci Capital | — |
| Mar 21, 2017 | EyeYon | $6.5M Series B | Gauss Medical, Rimonci Capital | Pontifax, Triventures |